Humana (HUM) shares surged 4% to $256.62, supported by high volume. The company reported progress in its Medicare star ratings, with 20% of members enrolled in 4-star plans for 2026. Humana also expects quarterly earnings of $2.88 per share and revenues of $31.92 billion, showing a strong competitive position.

Humana offers a wide range of Medicare Advantage, Prescription Drug, and Supplement plans in the US, emphasizing integrated care and preventive services. Despite a projected -30.8% year-over-year change in earnings, the stock has a Zacks Rank #3. Investors should monitor any future earnings estimate revisions for potential stock strength.

Cigna (CI), another player in the Medical – HMOs industry, saw a 1.8% rise to $296.98. CI’s consensus EPS estimate for the upcoming report is $7.7, up +2.5% from last year. With a Zacks Rank of #3, Cigna is also expected to deliver solid performance. Investors can explore both Humana and Cigna for potential investment opportunities.

Read more at Nasdaq: Humana (HUM) Moves 4.0% Higher: Will This Strength Last?